New antibiotic dosing method could cut infections after heart surgery
NCT ID NCT07658378
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two ways of giving the antibiotic cefazolin during coronary artery bypass surgery to prevent wound infections. One group gets the drug as a steady drip (continuous infusion), the other as standard short injections. The trial will enroll 100 adults in Egypt and track how many develop a surgical site infection. If the continuous method works better, it could change how antibiotics are given during heart surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cefazolin
What this could lead to
If continuous infusion works better, it could become a new standard to prevent infections after heart bypass surgery.
What could go wrong
This is a small, early-phase trial in one country, so results may not apply everywhere. The difference between the two methods may be small or not meaningful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL SITE INFECTION (SSI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••